ONENESS BIOTECH CO., LTD.

ACTIVE

11F., No.236, Sec. 4, Xinyi Rd., 台湾 Taipei, 台湾省, Taiwanwww.onenessbio.com.twPublic51–100 employeesEstablished: 2008-06-01

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2008

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

40.0%

Phase 1

25.0%

Not Applicable

10.0%

Phase 3

10.0%

Phase 4

10.0%

Trial Status Distribution

Active, not recruiting

15.0%

Completed

40.0%

Not yet recruiting

5.0%

Recruiting

15.0%

Terminated

20.0%

Unknown

5.0%

Clinical Trials

Trials sponsored by this organization (20)

PREPUP: A Randomized Trial of Bonvadis® Versus Collagenase Ointment in Diabetic Foot Ulcers

Not Applicable

Not yet recruiting

interventional

Aug 2026100 participants

Assess the Safety and Tolerability of SNS851 in Study Participants

Phase 1

Recruiting

interventional

Apr 202652 participants

Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers

Phase 2

Active, not recruiting

interventional

Aug 2024120 participants

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Phase 2

Recruiting

interventional

Aug 202490 participants

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Phase 2

Active, not recruiting

interventional

Sep 2023135 participants

A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults

Phase 1

Active, not recruiting

interventional

May 202322 participants

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Phase 1

Completed

interventional

Nov 202244 participants

Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)

Phase 4

Terminated

interventional

Aug 20223 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations